MIRS:一种AI评分系统,用于预测乳腺癌的预后和治疗

Chen Huang1,2, Min Deng3, Dongliang Leng3

  • 1Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, Macau University of Science and Technology, Macau SAR 999078, China.

iScience
|November 29, 2023
PubMed
概括

一个新的转移和免疫基因组风险评分 (MIRS) 预测了乳腺癌患者的结果. MIRS对患者进行分层,指导个性化治疗策略,以改善生存和治疗反应.